Thank you.
Now I will go to Mr. Lexchin.
You obviously come at this with many years of experience. You touched upon how there was an exodus of vaccine manufacturers from Canada, starting in 2007, which was AstraZeneca, then in 2010 Johnson & Johnson, in 2011 Teva, and in 2013 Boehringer. It's also important to bear in mind that the previous government did not understand the significance of investing in life sciences.
How critical were these developments in terms of hollowing out our capacity to develop vaccines here at home in Canada?